Englander Institute for Precision Medicine

An atlas of bacterial serine-threonine kinases reveals functional diversity and key distinctions from eukaryotic kinases.

TitleAn atlas of bacterial serine-threonine kinases reveals functional diversity and key distinctions from eukaryotic kinases.
Publication TypeJournal Article
Year of Publication2025
AuthorsO'Boyle B, Yeung W, Lu JD, Katiyar S, Yaron-Barir TM, Johnson JL, Cantley LC, Kannan N
JournalSci Signal
Volume18
Issue885
Paginationeadt8686
Date Published2025 May 06
ISSN1937-9145
KeywordsAmino Acid Sequence, Bacteria, Bacterial Proteins, Catalytic Domain, Databases, Protein, Eukaryota, Evolution, Molecular, Mycobacterium tuberculosis, Protein Serine-Threonine Kinases, Signal Transduction, Substrate Specificity
Abstract

Bacterial serine-threonine kinases (STKs) regulate diverse cellular processes associated with cell growth, virulence, and pathogenicity and are evolutionarily related to the druggable eukaryotic STKs. A deeper understanding of how bacterial STKs differ from their eukaryotic counterparts and how they have evolved to regulate diverse bacterial signaling functions is crucial for advancing the discovery and development of new antibiotic therapies. Here, we classified more than 300,000 bacterial STK sequences from the NCBI RefSeq nonredundant and UniProt protein databases into 35 canonical and seven pseudokinase families on the basis of the patterns of evolutionary constraints in the conserved catalytic domain and flanking regulatory domains. Through statistical comparisons, we identified features distinguishing bacterial STKs from eukaryotic STKs, including an arginine residue in a regulatory helix (C helix) that dynamically couples the ATP- and substrate-binding lobes of the kinase domain. Biochemical and peptide library screens demonstrated that evolutionarily constrained residues contributed to substrate specificity and kinase activation in the Mycobacterium tuberculosis kinase PknB. Together, these findings open previously unidentified avenues for investigating bacterial STK functions in cellular signaling and for developing selective bacterial STK inhibitors.

DOI10.1126/scisignal.adt8686
Alternate JournalSci Signal
PubMed ID40327749

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021